PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnership with Pfizer Inc. (NYSE: PFE) with the goal of accelerating small molecule drug discovery by developing a platform technology based on generative chemistry. PostEra’s machine learning technology is intended to accelerate the drug discovery process by designing […]
